$110.60 -3.41 (%) Celgene Corp - NASDAQ

Aug. 24, 2016 | 04:00 PM

Partner Headlines

  1. Celgene Upgraded; Alibaba Price Target Bullish; Square, EA Targets Hiked

    Investors Business Daily | Aug. 4, 2016 | 09:28AM EST
  2. 2 Biotech Funds Leading Nascent Bull Market: Which Is Right For You?

    Investors Business Daily | Aug. 2, 2016 | 16:09PM EST
  3. QQQ ETF Posts 52-Week High; Energy Stocks Sag As Oil Drops To $40

    Investors Business Daily | Aug. 1, 2016 | 18:08PM EST
  4. What's Driving The Biotech Stock Rally? And Will It Last?

    Investors Business Daily | Aug. 1, 2016 | 15:15PM EST
  5. Are Biotechs Finally Making A Comeback? Here Are 5 Must-Watch Names

    Investors Business Daily | Aug. 1, 2016 | 12:20PM EST
  6. Apple, Facebook, Alphabet, Amazon, Ford, McDonald's Headline Busy Week

    Investors Business Daily | Jul. 29, 2016 | 12:13PM EST
  7. Stock Indexes Add Tiny Gains, But Biotech Celgene Rockets; Is It Time To Buy?

    Investors Business Daily | Jul. 28, 2016 | 16:40PM EST
  8. 3 Big Drugmakers That Beat Wall Street Q2 Estimates Thursday

    Investors Business Daily | Jul. 28, 2016 | 10:30AM EST
  9. Amazon, Alphabet, Baidu, Ford, Celgene On Tap Thursday

    Investors Business Daily | Jul. 27, 2016 | 17:45PM EST
  10. Investing Action Plan: Amazon, Alphabet, Baidu, Ford, Celgene

    Investors Business Daily | Jul. 27, 2016 | 13:51PM EST
  11. Celgene Slides After Deciding Against Revlimid Label Expansion

    Investors Business Daily | Jul. 26, 2016 | 12:27PM EST
  12. Celgene Falls After Blockbuster Cancer Drug Revlimid Fails To Extend Survival

    Investors Business Daily | Jul. 25, 2016 | 18:08PM EST
  13. This Week Could Decide Whether Biotech ETFs' Rally Sizzles Or Fizzles

    Investors Business Daily | Jul. 25, 2016 | 05:00AM EST
  14. Investing Action Plan: Apple, Facebook, Amazon, Big Oil, Boeing, Fed

    Investors Business Daily | Jul. 23, 2016 | 08:00AM EST
  15. 5 Big Drugmakers Reporting Earnings Next Week

    Investors Business Daily | Jul. 22, 2016 | 13:57PM EST
  16. Bluebird Bio Starts First CAR-T Cancer Trial; Juno Gets An Upgrade

    IBD | Feb. 17, 2016 | 14:28PM EST
  17. Bluebird Bio Gains 9% After Co. Begins New Phase 1 Study

    Benzinga | Feb. 17, 2016 | 12:52PM EST
  18. This Mutual Fund Is Powered By Twin Growth Engines

    IBD | Feb. 11, 2016 | 14:20PM EST
  19. Gilead, Johnson & Johnson or Roche?

    GuruFocus | Feb. 11, 2016 | 12:15PM EST
  20. Icahn, Gilead, GE Lead Top Insider Trades Of The Week

    Benzinga | Feb. 9, 2016 | 16:07PM EST
  21. Biotech Stocks Slip As Hugely Popular Momentum ETF Makes A Big Change

    IBD | Feb. 9, 2016 | 12:41PM EST
  22. Barron's: Here Comes $20 Oil

    Benzinga | Feb. 7, 2016 | 11:12AM EST
  23. LinkedIn Downgraded; Biotechs Initiated; Tableau PT Cut

    IBD | Feb. 5, 2016 | 09:16AM EST
  24. Maybe Some Good News For A Big Biotech ETF

    Benzinga | Jan. 29, 2016 | 08:39AM EST
  25. Celgene Dips Lower Following Q4 Print

    Benzinga | Jan. 28, 2016 | 09:06AM EST
  26. Jim Cramer Dishes On Microsoft, Gilead, TG Therapeutics & NY Community Bancorp

    Benzinga | Jan. 24, 2016 | 19:56PM EST
  27. Big Earnings Expectations For Big Biotech

    Benzinga | Jan. 24, 2016 | 16:55PM EST
  28. Juno Buyout Puts Single-Cell Sequencing In Spotlight

    IBD | Jan. 15, 2016 | 17:30PM EST
  29. Stocks Reverse Higher To Big Gains; Intel Falls After Q4 Results

    IBD | Jan. 14, 2016 | 16:29PM EST
  30. Celgene Disappoints, Dips

    IBD | Jan. 11, 2016 | 19:29PM EST
  31. Celgene, Vertex, Illumina Offer Mixed Outlooks

    IBD | Jan. 11, 2016 | 19:05PM EST
  32. Stocks End Mixed; Alcoa Rises After Hours On Earnings

    IBD | Jan. 11, 2016 | 16:26PM EST
  33. Celgene Numbers Disappoint; New CEO Announced

    IBD | Jan. 11, 2016 | 13:59PM EST
  34. Stocks Turn Red As Biotechs, Energy Sink, But Macy's Rallies

    IBD | Jan. 11, 2016 | 13:44PM EST
  35. Baxalta Board Finally Accepts Shire's Takeover Offer

    IBD | Jan. 11, 2016 | 12:24PM EST
  36. Shares Of Celgene Plunge Following Busy Slate Of Announcements At JPMorgan Conference

    Benzinga | Jan. 11, 2016 | 12:02PM EST
  37. Celege 2016 Exp. Operational Milestones

    Benzinga | Jan. 11, 2016 | 11:13AM EST
  38. Benzinga's Top Initiations

    Benzinga | Jan. 7, 2016 | 09:37AM EST
  39. Jim Cramer Gives His Opinion On Lockheed Martin And Gilead Sciences

    Benzinga | Jan. 7, 2016 | 06:35AM EST
  40. DISH Network, H&R Block, Celgene, Plum Creek Timber Log Largest Insider Sells

    GuruFocus | Jan. 4, 2016 | 12:50PM EST
  41. Alphabet, Palo Alto Networks Lead Week's Insider Deals

    IBD | Dec. 31, 2015 | 13:59PM EST
  42. New IBD 50 Tech Stocks: LinkedIn Not The Only Network

    IBD | Dec. 28, 2015 | 19:13PM EST
  43. Celgene, Avago Lead IBD 50 Stocks For 'Santa Rally'

    IBD | Dec. 26, 2015 | 08:02AM EST
  44. Benzinga's Top #PreMarket Gainers

    Benzinga | Dec. 24, 2015 | 08:19AM EST
  45. Benzinga's Volume Movers

    Benzinga | Dec. 23, 2015 | 10:28AM EST
  46. Stock Futures Catch Oil Updraft; Nike Rumbles, Micron Takes a Hit

    IBD | Dec. 23, 2015 | 09:02AM EST
  47. Benzinga's Top #PreMarket Gainers

    Benzinga | Dec. 23, 2015 | 08:08AM EST
  48. Celgene Settles Patent Case

    IBD | Dec. 22, 2015 | 18:55PM EST
  49. After-Hours Action: Nike, Apple, Micron, Celgene

    IBD | Dec. 22, 2015 | 18:53PM EST
  50. After-Hours Movers Led By Nike, Micron, Celgene And CalAmp

    Benzinga | Dec. 22, 2015 | 17:13PM EST
Trading Center